Products for Research Use Only
RegisterLogin

TAT-QFNP12

CAT: 0804-HY-P10359Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10359Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TAT-QFNP12 is a peptide that blocks the NDRG2-PPM1A binding and reduces Smad2/3 phosphorylation, decreases astrocytic MMP-9 production and BBB disruption after subarachnoid hemorrhage (SAH) [1].
UNSPSC
12352209
Target
MMP; TGF-beta/Smad
Related Pathways
Metabolic Enzyme/Protease; Stem Cell/Wnt; TGF-beta/Smad
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Solubility
10 mM in DMSO
Smiles
O=C(NCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CCC(O)=O)C(N[C@@H](C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC2=CC=C(C=C2)O)N
Molecular Formula
C130H225N47O35
Molecular Weight
3006.47
References & Citations
[1]Feng D, et al. Astrocytic NDRG2-PPM1A interaction exacerbates blood-brain barrier disruption after subarachnoid hemorrhage. Sci Adv. 2022 Sep 30;8 (39) :eabq2423.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P0281-01TAT
HY-P11117-01TAT-EE3
HY-P10995TAT-327
HY-P0282TAT peptide
HY-P5883-01TAT-M2NX
HY-P10357TAT-CBD3
HY-P10465TRPV1-Tat
HY-P10638-01TAT-CN21
HY-P2193-01TAT-amide
HY-P10438-01TAT-Braftide

Alternative Products

CatalogName
TP3284-01TAT-QFNP12
GTR19035748-01Tat-QFNP12 TFA
GTR19150272-01TAT-QFNP12 acetate
068-27TAT Derivative, R9-Tat
abx600294-01Protein Tat (TAT) Protein
404990-01TAT
E8ER1919-19α-TAT

Popular Products